메뉴 건너뛰기




Volumn 12, Issue 2, 2015, Pages 135-140

Antipsychotics-associated serious adverse events in children: An analysis of the faers database

Author keywords

Antipsychotics; Children; Data mining; FAERS; Pharmacovigilance; Serious adverse events

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; THIAZOLE DERIVATIVE;

EID: 84961290413     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.10453     Document Type: Article
Times cited : (38)

References (34)
  • 1
    • 58049157203 scopus 로고    scopus 로고
    • Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis
    • Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009; 373: 31-41.
    • (2009) Lancet , vol.373 , pp. 31-41
    • Leucht, S.1    Corves, C.2    Arbter, D.3
  • 2
    • 84878877318 scopus 로고    scopus 로고
    • Efficacy and safety of individual second-generation vs. First-generation antipsychotics in first-episode psychosis: A systematic review and meta-analysis
    • Zhang JP, Gallego JA, Robinson DG, et al. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013; 16: 1205-1218.
    • (2013) Int J Neuropsychopharmacol , vol.16 , pp. 1205-1218
    • Zhang, J.P.1    Gallego, J.A.2    Robinson, D.G.3
  • 3
    • 0029046408 scopus 로고
    • Treatment of schizophrenia
    • Kane JM, McGlashan TH. Treatment of schizophrenia. Lancet. 1995; 346: 820-825.
    • (1995) Lancet , vol.346 , pp. 820-825
    • Kane, J.M.1    McGlashan, T.H.2
  • 4
    • 33845592951 scopus 로고    scopus 로고
    • Adverse effects of atypical antipsychotics in the elderly. A review
    • Gareri P, Fazio PD, Fazio SD, et al. Adverse effects of atypical antipsychotics in the elderly. A review. Drugs Aging. 2006; 23: 937-956.
    • (2006) Drugs Aging , vol.23 , pp. 937-956
    • Gareri, P.1    Fazio, P.D.2    Fazio, S.D.3
  • 5
    • 84897991128 scopus 로고    scopus 로고
    • Adverse effects associated with second-generation antipsychotic long-acting injection treatment: A Comprehensive Systematic Review
    • Gentile S. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: A Comprehensive Systematic Review. Pharmacotherapy. 2013; 33: 1087-1106.
    • (2013) Pharmacotherapy , vol.33 , pp. 1087-1106
    • Gentile, S.1
  • 6
    • 78751691883 scopus 로고    scopus 로고
    • Increasing off-label use of antipsychotics medications in the United States. 1995-2008
    • Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotics medications in the United States. 1995-2008. Pharmacoepidemiol Drug Saf. 2011; 20: 177-184.
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , pp. 177-184
    • Alexander, G.C.1    Gallagher, S.A.2    Mascola, A.3
  • 7
    • 84857167127 scopus 로고    scopus 로고
    • Antipsychotic Medication Prescribing Trends in Children and Adolescents
    • Harrison JN, Cluxton-Keller F, Gross D. Antipsychotic Medication Prescribing Trends in Children and Adolescents. J Pediatr Health Care. 2012; 2: 139-145.
    • (2012) J Pediatr Health Care , vol.2 , pp. 139-145
    • Harrison, J.N.1    Cluxton-Keller, F.2    Gross, D.3
  • 8
    • 44449097249 scopus 로고    scopus 로고
    • Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom
    • Rani F, Murray ML, Byrn PJ, et al. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics. 2008; 121: 1002-1009.
    • (2008) Pediatrics , vol.121 , pp. 1002-1009
    • Rani, F.1    Murray, M.L.2    Byrn, P.J.3
  • 9
    • 59049100725 scopus 로고    scopus 로고
    • Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: An overview of reports. 2003-2007
    • Johann-Liang R, Wyeth J, Chen M, et al. Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: an overview of reports. 2003-2007. Pharmacoepidemiol Drug Saf. 2009; 18(1):24-27.
    • (2009) Pharmacoepidemiol Drug Saf , vol.18 , Issue.1 , pp. 24-27
    • Johann-Liang, R.1    Wyeth, J.2    Chen, M.3
  • 10
    • 0035700740 scopus 로고    scopus 로고
    • Use of Proportional Reporting Ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
    • Evans SJ, Waller PC, Davis S. Use of Proportional Reporting Ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf, 2001; 10: 483-486.
    • (2001) Pharmacoepidemiol Drug Saf , vol.10 , pp. 483-486
    • Evans, S.J.1    Waller, P.C.2    Davis, S.3
  • 11
    • 0036210975 scopus 로고    scopus 로고
    • A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
    • Van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002; 11: 3-10.
    • (2002) Pharmacoepidemiol Drug Saf , vol.11 , pp. 3-10
    • Van Puijenbroek, E.P.1    Bate, A.2    Leufkens, H.G.3
  • 12
    • 0031871338 scopus 로고    scopus 로고
    • A Bayesian neural network method for adverse drug reaction signal generation
    • Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998; 54:315-321.
    • (1998) Eur J Clin Pharmacol , vol.54 , pp. 315-321
    • Bate, A.1    Lindquist, M.2    Edwards, I.R.3
  • 13
    • 0036300732 scopus 로고    scopus 로고
    • Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database
    • Szarfman A, Machao SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002; 25: 381-392.
    • (2002) Drug Saf , vol.25 , pp. 381-392
    • Szarfman, A.1    Machao, S.G.2    O’Neill, R.T.3
  • 14
    • 68149124572 scopus 로고    scopus 로고
    • Quantitative signal detection using spontaneous ADR reporting
    • Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009; 18: 427-436.
    • (2009) Pharmacoepidemiol Drug Saf , vol.18 , pp. 427-436
    • Bate, A.1    Evans, S.J.2
  • 15
    • 9144239875 scopus 로고    scopus 로고
    • Drug-induced pancreatitis: Lessons in data mining
    • Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol. 2004; 58: 560-562.
    • (2004) Br J Clin Pharmacol , vol.58 , pp. 560-562
    • Hauben, M.1    Reich, L.2
  • 16
    • 26944491481 scopus 로고    scopus 로고
    • Perspectives on the use of data mining in pharmacovigilance
    • Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf. 2005; 28: 981-1007.
    • (2005) Drug Saf , vol.28 , pp. 981-1007
    • Almenoff, J.1    Tonning, J.M.2    Gould, A.L.3
  • 17
    • 34447520376 scopus 로고    scopus 로고
    • Novel statistical tools for monitoring the safety of marketed drugs
    • Almenoff JS, Pattishall EN, Gibbs TG, et al. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007; 82: 157-166.
    • (2007) Clin Pharmacol Ther , vol.82 , pp. 157-166
    • Almenoff, J.S.1    Pattishall, E.N.2    Gibbs, T.G.3
  • 18
    • 62849083003 scopus 로고    scopus 로고
    • Decision support methods for the detection of adverse events in post-marketing data
    • Hauben M, Bate A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov Today. 2009; 14: 343-357.
    • (2009) Drug Discov Today , vol.14 , pp. 343-357
    • Hauben, M.1    Bate, A.2
  • 20
    • 69549114805 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: A review
    • Neuhut R, Lindenmayer JP, Silva R. Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: A review. J Child Adolesc Psychopharmacol. 2009; 19: 415-422.
    • (2009) J Child Adolesc Psychopharmacol , vol.19 , pp. 415-422
    • Neuhut, R.1    Lindenmayer, J.P.2    Silva, R.3
  • 21
    • 84880540083 scopus 로고    scopus 로고
    • Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: Theoretical background and practical recommendations
    • Cerovecki A, Musil R, Klimke A, et al. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs. 2013; 27: 545-572.
    • (2013) CNS Drugs , vol.27 , pp. 545-572
    • Cerovecki, A.1    Musil, R.2    Klimke, A.3
  • 22
    • 84869084282 scopus 로고    scopus 로고
    • Toxicology and overdose of atypical antipsychotics
    • Minns AB, Clark RF. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 2012; 43: 906-913.
    • (2012) J Emerg Med , vol.43 , pp. 906-913
    • Minns, A.B.1    Clark, R.F.2
  • 23
    • 77649273872 scopus 로고    scopus 로고
    • QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia
    • Ozeki Y, Fujii K, Kurimoto N, et al. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34: 401-405.
    • (2010) Prog Neuropsychopharmacol Biol Psychiatry , vol.34 , pp. 401-405
    • Ozeki, Y.1    Fujii, K.2    Kurimoto, N.3
  • 24
    • 84878698751 scopus 로고    scopus 로고
    • Antipsychotics and torsadogenic risk: Signals emerging from the US FDA Adverse Event Reporting System database
    • Poluzzi E, Raschi E, Koci A, et al. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf. 2013; 36: 467-479.
    • (2013) Drug Saf , vol.36 , pp. 467-479
    • Poluzzi, E.1    Raschi, E.2    Koci, A.3
  • 25
    • 82155164409 scopus 로고    scopus 로고
    • QTc prolongation by psychotropic drugs and the risk of torsade de pointes
    • Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of torsade de pointes. Dtsch Arztebl Int. 2011; 108: 687-693.
    • (2011) Dtsch Arztebl Int , vol.108 , pp. 687-693
    • Wenzel-Seifert, K.1    Wittmann, M.2    Haen, E.3
  • 26
    • 84875447775 scopus 로고    scopus 로고
    • Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia
    • Maher KN, Tan M, Tossell JW, et al. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia. J child adolesc psychopharmacol. 2013; 23: 110-116.
    • (2013) J Child Adolesc Psychopharmacol , vol.23 , pp. 110-116
    • Maher, K.N.1    Tan, M.2    Tossell, J.W.3
  • 27
    • 84892535501 scopus 로고    scopus 로고
    • Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
    • Schneider C, Corrigall R, Hayes D, et al. Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia. Eur Psychiatry. 2014; 29: 1-10.
    • (2014) Eur Psychiatry , vol.29 , pp. 1-10
    • Schneider, C.1    Corrigall, R.2    Hayes, D.3
  • 28
    • 84872421868 scopus 로고    scopus 로고
    • Risperidone-induced leucopenia: A case report and brief review of literature
    • Manfredi G, Solfanelli A, Dimitri G, et al. Risperidone-induced leucopenia: a case report and brief review of literature. Gen Hosp Psychiatry. 2013; 35: 102.e3-102.e6.
    • (2013) Gen Hosp Psychiatry , vol.35 , pp. e3-e6
    • Manfredi, G.1    Solfanelli, A.2    Dimitri, G.3
  • 29
    • 0033711684 scopus 로고    scopus 로고
    • A case of leukopenia in treatment with risperidone in an adolescent
    • Etain B, Roubaud L, Le Heuzey MF et al. A case of leukopenia in treatment with risperidone in an adolescent. Encepahle. 2000; 26: 81-84.
    • (2000) Encepahle , vol.26 , pp. 81-84
    • Etain, B.1    Roubaud, L.2    Le Heuzey, M.F.3
  • 30
    • 0037227192 scopus 로고    scopus 로고
    • Clozapine treatment for suicidality in schizopherenia: Internal Suicide Prevention Trial
    • Meltzer HY, Alphs L, Green AI et al. Clozapine treatment for suicidality in schizopherenia: Internal Suicide Prevention Trial. Arch Gen Psychiatry. 2003; 60: 82-91.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 82-91
    • Meltzer, H.Y.1    Alphs, L.2    Green, A.I.3
  • 31
    • 68949172254 scopus 로고    scopus 로고
    • 11-year Follow-Up of Mortality in Patients with Schizophrenia: A Population-Based Cohort Study (FIN11 Study)
    • Tiihonen J, Loonqvist J, Wahlbeck K, et al. 11-year Follow-Up of Mortality in Patients with Schizophrenia: A Population-Based Cohort Study (FIN11 Study). Lancet. 2009; 374: 620-627.
    • (2009) Lancet , vol.374 , pp. 620-627
    • Tiihonen, J.1    Loonqvist, J.2    Wahlbeck, K.3
  • 32
    • 77958198145 scopus 로고    scopus 로고
    • Suicide attempts in a prospective cohort of patients with schizophrenia treated with Sertindole or Riperidone
    • Crocq MA, Naber D, Lader MH, et al. Suicide attempts in a prospective cohort of patients with schizophrenia treated with Sertindole or Riperidone. Eur Neuropsychopharmaco. 2010; 20: 829-838.
    • (2010) Eur Neuropsychopharmaco , vol.20 , pp. 829-838
    • Crocq, M.A.1    Naber, D.2    Lader, M.H.3
  • 33
    • 48249105115 scopus 로고    scopus 로고
    • Association between medication and Risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia
    • Haukka J, Tiihonen J, Harkanen T, et al. Association between medication and Risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiol Drug Saf. 2008; 17: 686-696.
    • (2008) Pharmacoepidemiol Drug Saf , vol.17 , pp. 686-696
    • Haukka, J.1    Tiihonen, J.2    Harkanen, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.